170 related articles for article (PubMed ID: 15752356)
1. Characterization of alpha-synuclein aggregation and synergistic toxicity with protein tau in yeast.
Zabrocki P; Pellens K; Vanhelmont T; Vandebroek T; Griffioen G; Wera S; Van Leuven F; Winderickx J
FEBS J; 2005 Mar; 272(6):1386-400. PubMed ID: 15752356
[TBL] [Abstract][Full Text] [Related]
2. Initiation and synergistic fibrillization of tau and alpha-synuclein.
Giasson BI; Forman MS; Higuchi M; Golbe LI; Graves CL; Kotzbauer PT; Trojanowski JQ; Lee VM
Science; 2003 Apr; 300(5619):636-40. PubMed ID: 12714745
[TBL] [Abstract][Full Text] [Related]
3. PA700, the regulatory complex of the 26S proteasome, interferes with alpha-synuclein assembly.
Ghee M; Melki R; Michot N; Mallet J
FEBS J; 2005 Aug; 272(16):4023-33. PubMed ID: 16098186
[TBL] [Abstract][Full Text] [Related]
4. Degradation of wild-type alpha-synuclein by a molecular chaperone leads to reduced aggregate formation.
Kong B; Chae Y; Lee K
Cell Biochem Funct; 2005; 23(2):125-32. PubMed ID: 15624119
[TBL] [Abstract][Full Text] [Related]
5. Nuclear localization of alpha-synuclein and its interaction with histones.
Goers J; Manning-Bog AB; McCormack AL; Millett IS; Doniach S; Di Monte DA; Uversky VN; Fink AL
Biochemistry; 2003 Jul; 42(28):8465-71. PubMed ID: 12859192
[TBL] [Abstract][Full Text] [Related]
6. The aggregation and membrane-binding properties of an alpha-synuclein peptide fragment.
Madine J; Doig AJ; Middleton DA
Biochem Soc Trans; 2004 Dec; 32(Pt 6):1127-9. PubMed ID: 15506987
[TBL] [Abstract][Full Text] [Related]
7. Geldanamycin induces Hsp70 and prevents alpha-synuclein aggregation and toxicity in vitro.
McLean PJ; Klucken J; Shin Y; Hyman BT
Biochem Biophys Res Commun; 2004 Aug; 321(3):665-9. PubMed ID: 15358157
[TBL] [Abstract][Full Text] [Related]
8. The stationary phase model of aging in yeast for the study of oxidative stress and age-related neurodegeneration.
Chen Q; Ding Q; Keller JN
Biogerontology; 2005; 6(1):1-13. PubMed ID: 15834659
[TBL] [Abstract][Full Text] [Related]
9. Alpha-synuclein has structural and functional similarities to small heat shock proteins.
Kim TD; Choi E; Rhim H; Paik SR; Yang CH
Biochem Biophys Res Commun; 2004 Nov; 324(4):1352-9. PubMed ID: 15504363
[TBL] [Abstract][Full Text] [Related]
10. alpha-Synuclein budding yeast model: toxicity enhanced by impaired proteasome and oxidative stress.
Sharma N; Brandis KA; Herrera SK; Johnson BE; Vaidya T; Shrestha R; Debburman SK
J Mol Neurosci; 2006; 28(2):161-78. PubMed ID: 16679556
[TBL] [Abstract][Full Text] [Related]
11. Effects of nitration on the structure and aggregation of alpha-synuclein.
Uversky VN; Yamin G; Munishkina LA; Karymov MA; Millett IS; Doniach S; Lyubchenko YL; Fink AL
Brain Res Mol Brain Res; 2005 Mar; 134(1):84-102. PubMed ID: 15790533
[TBL] [Abstract][Full Text] [Related]
12. Impaired degradation of mutant alpha-synuclein by chaperone-mediated autophagy.
Cuervo AM; Stefanis L; Fredenburg R; Lansbury PT; Sulzer D
Science; 2004 Aug; 305(5688):1292-5. PubMed ID: 15333840
[TBL] [Abstract][Full Text] [Related]
13. Heat shock prevents alpha-synuclein-induced apoptosis in a yeast model of Parkinson's disease.
Flower TR; Chesnokova LS; Froelich CA; Dixon C; Witt SN
J Mol Biol; 2005 Sep; 351(5):1081-100. PubMed ID: 16051265
[TBL] [Abstract][Full Text] [Related]
14. Covalent blocking of fibril formation and aggregation of intracellular amyloidgenic proteins by transglutaminase-catalyzed intramolecular cross-linking.
Konno T; Morii T; Hirata A; Sato S; Oiki S; Ikura K
Biochemistry; 2005 Feb; 44(6):2072-9. PubMed ID: 15697232
[TBL] [Abstract][Full Text] [Related]
15. Dopamine transporter-mediated cytotoxicity of 6-hydroxydopamine in vitro depends on expression of mutant alpha-synucleins related to Parkinson's disease.
Lehmensiek V; Tan EM; Liebau S; Lenk T; Zettlmeisl H; Schwarz J; Storch A
Neurochem Int; 2006 Apr; 48(5):329-40. PubMed ID: 16406146
[TBL] [Abstract][Full Text] [Related]
16. Impairment of redox state and dopamine level induced by alpha-synuclein aggregation and the prevention effect of hsp70.
Yu F; Xu H; Zhuo M; Sun L; Dong A; Liu X
Biochem Biophys Res Commun; 2005 May; 331(1):278-84. PubMed ID: 15845390
[TBL] [Abstract][Full Text] [Related]
17. Following the leader: fibrillization of alpha-synuclein and tau.
Frasier M; Wolozin B
Exp Neurol; 2004 Jun; 187(2):235-9. PubMed ID: 15144849
[No Abstract] [Full Text] [Related]
18. Cytokines disrupt intracellular patterns of Parkinson's disease-associated proteins alpha-synuclein, tau and ubiquitin in cultured glial cells.
Bick RJ; Poindexter BJ; Kott MM; Liang YA; Dinh K; Kaur B; Bick DL; Doursout MF; Schiess MC
Brain Res; 2008 Jun; 1217():203-12. PubMed ID: 18501880
[TBL] [Abstract][Full Text] [Related]
19. Pathogenic effects of alpha-synuclein aggregation.
Lundvig D; Lindersson E; Jensen PH
Brain Res Mol Brain Res; 2005 Mar; 134(1):3-17. PubMed ID: 15790525
[TBL] [Abstract][Full Text] [Related]
20. Alpha-synuclein aggregation variable temperature and variable pH kinetic data: a re-analysis using the Finke-Watzky 2-step model of nucleation and autocatalytic growth.
Morris AM; Finke RG
Biophys Chem; 2009 Mar; 140(1-3):9-15. PubMed ID: 19101068
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
